© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
June 19, 2014
A recent review found that tonabersat, a novel benzoylamino benzopyran compound, is well-tolerated, but no better than placebo for migraine prophylaxis.
April 09, 2014
Patients who also responded positively to preoperative non-invasive transcranial stimulation analgesic effect were more likely to experience long-term benefit from MCS.
March 12, 2014
According to a recent systematic review, the prescient and short-term use of NSAIDs and opioids with pharmacological sensitivity to an individual's comorbidities may result in pain relief, improved functioning, and reduced vocational and avocational absenteeism.
February 13, 2014
Meta-analysis of clinical trial data on the use of antidepressants and anticonvulsants for the treatment of painful diabetic neuropathy indicates gabapentin is the most efficacious agent for this condition, while the side effects associated with amitriptyline make it the least tolerable treatment option evaluated in the study.
Wonder Drake, MD: Sarcoidosis is a Disease of Exclusion
FDA Approves Dupilumab for Eosinophilic Esophagitis
New 52-Week Data Finds Guselkumab Well Tolerated in Moderate to Severe Psoriasis